HTRA1 and TGF-β1 Concentrations in the Aqueous Humor of Patients With Neovascular Age-Related Macular Degeneration
Author(s) -
Gian Marco Tosi,
Elena Caldi,
Giovanni Neri,
Elisabetta Nuti,
Davide Marigliani,
Stefano Baiocchi,
Claudio Traversi,
Gabriele Cevenini,
Antonio Tarantello,
Fiorella Fusco,
Federica Nardi,
Maurizio Orlandini,
Federico Galvagni
Publication year - 2017
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.16-20922
Subject(s) - macular degeneration , ranibizumab , medicine , choroidal neovascularization , neovascularization , ophthalmology , vascular endothelial growth factor a , vascular endothelial growth factor , transforming growth factor , endocrinology , vegf receptors , angiogenesis , bevacizumab , chemotherapy
The purpose of this study was to evaluate the expression of high-temperature requirement A serine peptidase 1 (HTRA1), TGF-β1, bone morphogenetic protein 4 (BMP4), growth differentiation factor 6 (GDF6), and VEGFA proteins in the aqueous humor of patients with naïve choroidal neovascularization (nCNV) secondary to AMD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom